Letrozole Versus Letrozole plus Lapatinib (GW572016) in Hormone-Sensitive, HER2-Negative Operable Breast Cancer: A Double-Blind, Randomized, Phase II Study with Biomarker Evaluation (EGF109077-LAP107692/LETLOB)

✍ Scribed by Antonio Frassoldati; Valentina Guarneri; Federico Piacentini; Gordana Jovic; Simona Giovannelli; Cristina Oliva; Pier Franco Conte

• Book ID: 119934791
• Publisher: CIG Media Group, LP.
• Year: 2008
• Tongue: English
• Weight: 88 KB
• Volume: 8
• Category: Article
• ISSN: 1526-8209
• DOI: 10.3816/cbc.2008.n.010